Journal article : Review
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
- Abstract:
-
Nephrology has benefited from conducting increasingly large high-quality trials in the last 5- 10 years. In addition to the long-standing known benefits of renin-angiotensin system inhibitors, we now have multiple pharmacotherapies that provide kidney and/or cardiovascular protection for certain types of patient with chronic kidney disease (CKD). These include sodium glucose co-transporter 2 inhibitors (SGLT2i), a non-steroidal mineralocorticoid receptor antagonist and a glucagon-like peptide...
Expand abstract
- Publication status:
- Accepted
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Oxford University Press
- Journal:
- Nephrology Dialysis Transplantation More from this journal
- Acceptance date:
- 2024-06-08
- EISSN:
-
1460-2385
- ISSN:
-
0931-0509
Item Description
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
2038561
- Local pid:
-
pubs:2038561
- Deposit date:
-
2024-10-14
Terms of use
- Notes:
- For the purpose of open access, the author(s) has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record